These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33848645)

  • 61. Surgical-pathologic risk factors and immunohistochemical markers of pelvic lymph node metastasis in stage IB1 cervical cancer.
    Hernandez E; De La Mota J; Thomas MB; Huang Y; Gaughan JP; Wang F
    J Low Genit Tract Dis; 2011 Oct; 15(4):303-8. PubMed ID: 21811179
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A Predictive Model for Parametrial Invasion in Patients With FIGO Stage IB Cervical Cancer: Individualized Approach for Primary Treatment.
    Kong TW; Piao X; Chang SJ; Paek J; Lee Y; Lee EJ; Ryu HS
    Int J Gynecol Cancer; 2016 Jan; 26(1):184-91. PubMed ID: 26512782
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of survival outcomes with or without Para-aortic lymphadenectomy in surgical patients with stage IB1-IIA2 cervical cancer in China from 2004 to 2016.
    Chen C; Duan H; Zhang W; Zhao H; Wang L; Kang S; Lin L; Zhao W; Ni Y; Li D; Chen J; Fan H; Chen X; Bin X; Lang J; Liu P
    BMC Cancer; 2021 Oct; 21(1):1091. PubMed ID: 34627169
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Do the pelvic lymph nodes predict the parametrial status in cervical cancer stages IB-IIA?
    Puente R; Guzman S; Israel E; Poblete MT
    Int J Gynecol Cancer; 2004; 14(5):832-40. PubMed ID: 15361191
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 Cervical Cancer with Negative Lymph Nodes.
    Wang R; Tao X; Wu X; Jiang H; Xia H
    J Minim Invasive Gynecol; 2020; 27(4):946-952. PubMed ID: 31394263
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Is radical hysterectomy necessary in early cervical cancer?
    Meirovitz M; Sade S; Dreiher J; Shaco-Levy R
    Gynecol Obstet Invest; 2013; 76(3):158-62. PubMed ID: 24051740
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
    Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
    Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Surgical Approach and Use of Uterine Manipulator Are Not Associated with LVSI in Surgery for Early-stage Cervical Cancer.
    Liu Y; Huang S; Ming X; Jing H; Li Z
    J Minim Invasive Gynecol; 2021 Sep; 28(9):1573-1578. PubMed ID: 33497723
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Oncologic outcome in patients with 2018 FIGO stage IB cervical cancer: Is tumor size important?
    Tokalioglu AA; Kilic C; Oktar O; Kilic F; Cakir C; Yuksel D; Comert GK; Korkmaz V; Turan T
    J Obstet Gynaecol Res; 2023 Feb; 49(2):709-716. PubMed ID: 36415110
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Conservative surgery in early-stage cervical cancer: what percentage of patients may be eligible for conization and lymphadenectomy?
    Smith AL; Frumovitz M; Schmeler KM; dos Reis R; Nick AM; Coleman RL; Ramirez PT
    Gynecol Oncol; 2010 Nov; 119(2):183-6. PubMed ID: 20708227
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Comparative analysis of the prognosis of patients with locally advanced cervical cancer undergoing laparoscopic or abdominal surgery].
    Xu YP; Wang ZQ; Liang XD; Wang Y; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2020 Sep; 55(9):609-616. PubMed ID: 32957749
    [No Abstract]   [Full Text] [Related]  

  • 73. Comedo-like growth pattern in invasive early-stage cervical cancer: A new feature related to parametrial involvement.
    Cosma S; Borella F; Grimaudo I; Seminara Y; Annalisa T; Bertero L; Goia M; Preti M; Benedetto C
    Eur J Surg Oncol; 2024 Jul; 50(7):108438. PubMed ID: 38815333
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
    Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter.
    Nicolai L; Yigit R; Bleeker MCG; Bart J; van der Velden J; Mom CH
    J Gynecol Oncol; 2023 Nov; 34(6):e75. PubMed ID: 37477098
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
    Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
    Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Conization and lymph node evaluation in low-risk cervical cancer. Is it time to avoid radical surgery? Retrospective series and literature review.
    Lucchini SM; Ferreyra HD; Landeros J; Esteban A; Donetch G; Goldsman MG; Borla HF; Heredia F
    Eur J Obstet Gynecol Reprod Biol; 2021 Nov; 266():163-168. PubMed ID: 34673464
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tumor Size at Magnetic Resonance Imaging Association With Lymph Node Metastasis and Lymphovascular Space Invasion in Resectable Cervical Cancer: A Multicenter Evaluation of Surgical Specimens.
    Chen XL; Chen GW; Xu GH; Ren J; Li ZL; Pu H; Li H
    Int J Gynecol Cancer; 2018 Oct; 28(8):1545-1552. PubMed ID: 30044321
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of a low risk population for parametrial invasion in patients with early-stage cervical cancer.
    Dabi Y; Willecocq C; Ballester M; Carcopino X; Bendifallah S; Ouldamer L; Lavoue V; Canlorbe G; Raimond E; Coutant C; Graesslin O; Collinet P; Bricou A; Huchon C; Daraï E; Haddad B; Touboul C;
    J Transl Med; 2018 Jun; 16(1):163. PubMed ID: 29898732
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Magnetic Resonance Imaging as a Valuable Tool for Predicting Parametrial Invasion in Stage IB1 to IIA2 Cervical Cancer.
    Kim M; Suh DH; Kim K; Lee HJ; Kim YB; No JH
    Int J Gynecol Cancer; 2017 Feb; 27(2):332-338. PubMed ID: 28114236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.